Notice

Selected as a recommended target for the 2023 excellent R&D innovative product designation system

Cylinder infusion pumps (Anyfusion cylinder pump H-100/Anyfusion cylinder pump V-100) and cylinder cartridges for cylinder infusion pumps have been selected for recommendation in the 2023 Excellent R&D Innovative Product Designation System (first half of the year) promoted by the Ministry of SMEs and Startups and the Korea Institute of Technology and Information Promotion (KITIP), as they received high ratings in the evaluation of the expert organization (management agency) in terms of technological R&D linkage, product core performance, technological innovation, marketability, and social necessity.
If it is designated as an excellent R&D innovative product for public procurement through the process of April legal consultation -> May procurement suitability review -> May comprehensive examination -> June procurement policy review, it will be a priority purchase target as an innovative product in the public procurement field of national military hospitals, veterans hospitals, police hospitals, and public hospitals (Seoul National University, local public universities, and medical centers).
More importantly, the message to the U.S. procurement market of about 800 trillion dollars, which is nearly 100 trillion dollars larger than the total budget of Korea, and the European public procurement market, which has the world's highest level of medical welfare, will be enormous. It is judged that the references and evidence of Korea's original technology innovations being used in the global public procurement market are reflective of the influence of social needs and marketability on the US and global public procurement markets.
 
According to the information provided to the Insurance Benefits Division of the Ministry of Health and Welfare, Anyfusion will be essential equipment for quantitative and accurate injection, including ambulances, police helicopters, airplanes, and high-altitude hospitals such as Nepal and Mexico, as it has no effect on air pressure and vibration. In addition, Inha University's Institute of Aerospace Medicine and the Korean Aerospace Society have determined that Anyfusion cylinder pump is likely to be selected as the optimal product to inject medicines into spacecraft, so it will be reflected in next year's national budget and applied to NASA spacecraft through product development and certification. If selected as essential medical equipment for NASA spacecraft, it is expected that the message to the world and the market will be high.


Thank you

Next Anyfusion ACPi system, Daegu K University Hospital and Italy G Company Milan University Hospital
Prev Interview with the Ministry of Health and Welfare (medical insurance)